Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 21 Lung Neoplasms 10 Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 6 Skin Neoplasms 6 Prostatic Neoplasms 5 Neoplasm Metastasis 5 Melanoma 5 Head and Neck Neoplasms 5 Urinary Bladder Neoplasms 4 Colorectal Neoplasms 4 Carcinoma, Renal Cell 4 Carcinoma, Merkel Cell 4 Breast Neoplasms 4 Sarcoma 3 Pancreatic Neoplasms 3 Mycosis Fungoides 3 Carcinoma, Squamous Cell 3 Carcinoma, Hepatocellular 3 Carcinoma, Basal Cell 3 Adenocarcinoma 3 Uterine Cervical Neoplasms 2 Triple Negative Breast Neoplasms 2 Thyroid Carcinoma, Anaplastic 2 Rectal Neoplasms 2 Oropharyngeal Neoplasms 2 Mouth Neoplasms 2 Mesothelioma, Malignant 2 Lymphoma, T-Cell 2 Lymphoma, Large-Cell, Anaplastic 2

Interventions

Surveys and Questionnaires 6 Methods 6 Radiotherapy 5 Cisplatin 5 pembrolizumab 4 durvalumab 3 Sentinel Lymph Node Biopsy 3 Radiosurgery 3 Palliative Care 3 Indocyanine Green 3 Early Intervention, Educational 3 Brachytherapy 3 Bleomycin 3 tremelimumab 2 aldesleukin 2 Surgical Procedures, Operative 2 Radiation 2 Paclitaxel 2 Interviews as Topic 2 Immunoglobulin G 2 Imiquimod 2 Gemcitabine 2 Electrochemotherapy 2 Drug Therapy 2 Disulfides 2 Dehydroepiandrosterone 2 Counseling 2 Carboplatin 2 Biopsy 2 Bevacizumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Vulvar Neoplasms × cemiplimab × Clear all

NCT07101848 2025-08-03

BRAVA VULVAR

Hospital Israelita Albert Einstein

Phase 2 Not yet recruiting

Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡